Your browser doesn't support javascript.
loading
Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction.
Shiba, Masayuki; Kato, Takao; Morimoto, Takeshi; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Seko, Yuta; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Yamashita, Yugo; Iguchi, Moritake; Nagao, Kazuya; Kawase, Yuichi; Morinaga, Takashi; Toyofuku, Mamoru; Furukawa, Yutaka; Ando, Kenji; Kadota, Kazushige; Sato, Yukihito; Kuwahara, Koichiro; Kimura, Takeshi.
Afiliación
  • Shiba M; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Kato T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. tkato75@kuhp.kyoto-u.ac.jp.
  • Morimoto T; Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Yaku H; Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
  • Inuzuka Y; Cardiovascular Medicine, Shiga General Hospital, Moriyama, Japan.
  • Tamaki Y; Division of Cardiology, Tenri Hospital, Tenri, Japan.
  • Ozasa N; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Seko Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Yamamoto E; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Yoshikawa Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Kitai T; Division of Heart Failure, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Yamashita Y; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Iguchi M; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Nagao K; Department of Cardiology, Osaka Red Cross Hospital, Osaka, Japan.
  • Kawase Y; Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Morinaga T; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
  • Toyofuku M; Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Furukawa Y; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ando K; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
  • Kadota K; Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Sato Y; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Kuwahara K; Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, Nagano, Japan.
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Sci Rep ; 12(1): 4473, 2022 03 16.
Article en En | MEDLINE | ID: mdl-35297403
ABSTRACT
We aimed to investigate the relationship between left atrial (LA) reverse remodeling and prognosis of heart failure (HF) with recovered ejection fraction (EF) (HFrecEF). Among 1,246 patients with acute heart failure enrolled in the prospective longitudinal follow-up study, 397 patients with HF with mildly-reduced EF and with reduced EF at discharge were analyzed. Echocardiography was performed during the index hospitalization and at the 6-month follow-up after discharge. They were divided into non-HFrecEF (n = 227) and HFrecEF (n = 170) groups. The primary outcome measure was a composite of all-cause death or hospitalization for HF. The cumulative 180-day incidence of the primary outcome measure after follow-up echocardiography was significantly lower in the HFrecEF group than in the non-HFrecEF group (8.9% versus 23.4%, log-rank P = 0.0002). LA reverse remodeling was associated with a lower cumulative 6-month incidence of the primary outcome measure in the HFrecEF group (4.7% versus 18.0%; HR 0.27, 95%CI 0.09-0.79, P = 0.01), but not in the non-HFrecEF group (24.4% versus 22.6%; HR 1.13, 95%CI 0.65-1.96, P = 0.28) with a significant LA reverse remodeling-by-HFrecEF interaction (P for interaction = 0.02). Combination of left ventricular and atrial reverse remodeling may help in improving HF risk stratification.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Disfunción Ventricular Izquierda / Remodelación Atrial / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Disfunción Ventricular Izquierda / Remodelación Atrial / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón
...